• MONIKA KHARB Department of Pharmaceutics, Bhupal Nobles’ College of Pharmacy, Faculty of Pharmacy, Bhupal Nobles’ University, Udaipur, Rajasthan, India
  • Y. S. TANWAR Department of Pharmaceutics, Bhupal Nobles’ College of Pharmacy, Faculty of Pharmacy, Bhupal Nobles’ University, Udaipur, Rajasthan, India


Objective: The aim of this study is to develop a gastroretentive microsphere of pregabalin using design of experiment (DoE) to decrease dosing frequency and increasing bioavailability.

Methods: Pregabalin microsphere was prepared by W/O/O multiple emulsion method using a mixture of ethyl cellulose (EC) and polyvinyl pyrrolidone (PVP) as rate-controlling polymer. Mixed solvent system comprising of dichloromethane (DCM) and acetonitrile (ACN) and light liquid paraffin was chosen as primary and secondary oil phase respectively. Taguchi design was employed for factor screening and Box Behnken design was used for the optimisation of critical process parameters.

Results: Taguchi design revealed that polymer: drug, DCM: ACN and PVP: EC is the critical factor for the preparation of microspheres. The optimized formulation was prepared using polymer: drug (4.95:1), DCM: ACN (53.76: 46.24) and PVP: EC (2:5) which showed mean particle size of 203.34±4.82 µm, practical yield of 87.52±2.91 %, encapsulation efficiency of 96.43±3.14 %, floating ability up to 90.42±1.64 % and T60% of 332.81±5.84. Drug release from microsphere followed Higuchi Kinetic model.

Conclusion: In a nutshell, microspheres with excellent flowability and great encapsulation efficiency were successfully developed. These can be useful in improving patient compliance by reducing frequent dosing.

Keywords: Gastroretantive, Microsphere, Pregabalin, Multiple emulsion method, Optimisation, Box Behnken design, Taguchi design


1. Viswanathan P, Muralidaran Y, Ragavan G. Challenges in oral drug delivery: a nano-based strategy to overcome. Nanostructures for oral medicine. Elsevier; 2017. p. 173-201.
2. Gupta U, Perumal O. Dendrimers and Its biomedical applications. Natural and Synthetic Biomedical Polymers. Elsevier; 2014. p. 243-57.
3. Bansal S, Beg S, Asthana A, Garg B, Asthana GS, Kapil R, et al. QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride. Drug Delivery 2016;23:437-51.
4. Awasthi R, Kulkarni GT. Development of novel gastroretentive drug delivery system of gliclazide: hollow beads. Drug Dev Ind Pharm 2014;40:398-408.
5. Jadi RK, Bomma R, Sellappan V. Development of a new single unit dosage form of propranolol HCl extended release non-effervescent floating matrix tablets: in vitro and in vivo evaluation. J Appl Pharm Sci 2016;6:112-8.
6. Garg R, Gupta G. Progress in controlled gastroretentive delivery systems. Trop J Pharm Res 2008;7:1055-66.
7. Farooq U, Khan S, Nawaz S, Ranjha NM, Haider MS, Khan MM, et al. Enhanced gastric retention and drug release via the development of novel floating microspheres based on Eudragit E100 and polycaprolactone: synthesis and in vitro evaluation. Des Monomers Polym 2017;20:419-33.
8. Oth M, Franz M, Timmermans J, Moes A. The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol. Pharm Res 1992;9:298-302.
9. Chen C, Han C-HS, Sweeney M, Cowles VE. Pharmacokinetics, efficacy, and tolerability of a once-daily gastroretentive dosage form of gabapentin for the treatment of postherpetic neuralgia. J Pharm Sci 2013;102:1155-64.
10. Agarwal S, Zamil F, Singh L, Saxena A. Formulation and evaluation of floating beads of diltiazem hcl. Int J Curr Pharm Res 2016;8:38-42.
11. Soppimath KS, Kulkarni AR, Aminabhavi TM. Development of hollow microspheres as floating controlled-release systems for cardiovascular drugs: preparation and release characteristics. Drug Dev Ind Pharm 2001;27:507-15.
12. Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci 1992;81:135-40.
13. Adebisi A, Conway BR. Gastroretentive microparticles for drug delivery applications. J Microencapsul 2011;28:689-708.
14. Kesharvani S, Jaiswal PK, Mukerjee A, Singh AK. Formulation and evaluation of metformin hydrochloride loaded floating microspheres. Int J Pharm Pharm Sci 2020;1:74-82.
15. Uchida T, Yoshida K, Goto S. Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method. J Microencapsul 1996;13:219-28.
16. Ashjari M, Khoee S, Mahdavian AR. Controlling the morphology and surface property of magnetic/cisplatin-loaded nanocapsules via W/O/W double emulsion method. Colloids Surf Physicochem Eng Aspects 2012;408:87-96.
17. Viswanathan NB, Thomas P, Pandit J, Kulkarni M, Mashelkar R. Preparation of non-porous microspheres with high entrapment efficiency of proteins by a (water-in-oil)-in-oil emulsion technique. J Controlled Release 1999;58:9-20.
18. Aydogan E, Comoglu T, Pehlivanoglu B, Dogan M, Comoglu S, Dogan A, et al. Process and formulation variables of pregabalin microspheres prepared by w/o/o double emulsion solvent diffusion method and their clinical application by animal modeling studies. Drug Dev Ind Pharm 2015;41:1311-20.
19. Tassone DM, Boyce E, Guyer J, Nuzum D. Pregabalin: a novel ?-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. Clin Ther 2007;29:26-48.
20. Kanwar N, Kumar R, Sarwal A, Sinha VR. Preparation and evaluation of floating tablets of pregabalin. Drug Dev Ind Pharm 2016;42:654-60.
21. Beg S, Rahman M, Panda SK, Alharbi KS, Alruwaili NK, Singh PK, et al. Nasal mucoadhesive microspheres of lercanidipine with improved systemic bioavailability and antihypertensive activity. J Pharm Innov 2020;206:1-10.
22. Beg S, Rahman M, Panda S. Pharmaceutical QbD: omnipresence in the product development lifecycle. Eur Pharm Rev 2017;22:58-64.
23. Mennini N, Furlanetto S, Cirri M, Mura P. Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-?-cyclodextrin-PVP complex. Eur J Pharm Biopharm 2012;80:67-75.
24. Hales D, Vlase L, Porav SA, Bodoki A, Barbu Tudoran L, Achim M, et al. A quality by design (QbD) study on enoxaparin sodium loaded polymeric microspheres for colon-specific delivery. Eur J Pharm Sci 2017;100:249-61.
25. Khanam N, Alam MI, Iqbal QMA, Ali MY, Siddiqui AUR. A review on optinization of drug delivery system with experimental designs. Int J Appl Pharm 2018;10:7-12.
26. Bhoop BS, Raza K, Beg S. Developing “optimized” drug products employing “designed” experiments. Chem Ind Dig 2013;23:70-6.
27. Pandit V, Pai RS, Yadav V, Devi K, Surekha B, Inamdar MN, et al. Pharmacokinetic and pharmacodynamic evaluation of floating microspheres of metformin hydrochloride. Drug Dev Ind Pharm 2013;39:117-27.
28. Gaur PK, Mishra S, Kumar A, Panda BP. Development and optimization of gastroretentive mucoadhesive microspheres of gabapentin by box–behnken design. Artif Cells Nanomed Biotechnol 2014;42:167-77.
29. Lee JH, Park TG, Choi HK. Development of oral drug delivery system using floating microspheres. J Microencapsul 1999;16:715-29.
30. Phalguna Y, Venkateshwarlu B, Gudas GK, Debnath S. HPMC microspheres of zidovudine for sustained release. Int J Pharm Pharm Sci 2010;2:41-3.
31. Qin C, Wu M, Xu S, Wang X, Shi W, Dong Y, et al. Design and optimization of the gastro-floating sustained-release tablet of pregabalin: in vitro and in vivo evaluation. Int J Pharm 2018;545:37-44.
32. Grzegorzewski P. Statistical tests for comparing pareto charts. Communications Numerical Anal 2012;1-12. DOI:10.5899/2012/cna-00110
33. Mokarram AR. Preparation and in vitro evaluation of indomethacin nanoparticles. Daru 2010;18:185.
34. Gupta R, Prajapati SK, Pattnaik S, Bhardwaj P. Formulation and evaluation of novel stomach specific floating microspheres bearing famotidine for treatment of gastric ulcer and their radiographic study. Asian Pac J Trop Biomed 2014;4:729-35.
35. Dey S, Pramanik S, Malgope A. Formulation and optimization of sustained release stavudine microspheres using response surface methodology. Int Sch Res Notices 2011. DOI:10.5402/2011/627623
36. Bhowmick A, Saha T, Karmoker JR, Reza MS. Design of experiment (doe) approach to prepare, characterize and optimize the gastroretentive mucoadhesive microspheres of repaglinide. Bangladesh Pharm J 2019;22:135-45.
37. Parikh K, Mundada P, Sawant K. Design and optimization of controlled release felbamate tablets by d-optimal mixture design: in vitro-in vivo evaluation. Indian J Pharm Sci 2019;81:71-81.
38. Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123-33.
86 Views | 41 Downloads
How to Cite
Original Article(s)